Why the study?
Do workplace screening programs improve the identification and treatment of undiagnosed hypertension in asymptomatic employees?
Population
31,281 asymptomatic employees from 21 self-insured employer groups
Design
Cohort
Follow-up
1 month
Authors
Loading...
Workplace screening may boost short-term hypertension detection in employees; leaves open whether it improves outcomes or warrants routine adoption.
Do workplace screening programs improve the identification and treatment of undiagnosed hypertension in asymptomatic employees?
Workplace screening programs significantly increase the short-term identification and pharmacological treatment of previously undiagnosed hypertension among employees.
Legorreta et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: